Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

The jumonji domain-containing protein 2 (JMJD2) subfamily of histone demethylases have been shown to catalyze demethylation of the methylated forms of histone 3 lysine 9 (H3K9) and H3K36 in vitro and in cells.1 Because histone demethylases are implicated in certain diseases, including cancer, selective inhibitors are candidate anticancer agents as well as potential tools for elucidating the biological functions of JMJDs.2 N-Oxalylglycine, the amide analog of α-ketoglutarate, is a cell permeable inhibitor of α-ketoglutarate-dependent enzymes, including JMJD2A, JMJD2C, and JMJD2E (IC50s = 250, 500, and 24 μM, respectively).3,4,5,6 It can also inhibit the prolyl hydroxylase domain-containing proteins PHD1 and PHD2 with IC50 values of 2.1 and 5.6 μM, respectively.4,5,7
WARNING This product is not for human or veterinary use.
1. Structure and function of histone H3 lysine 9 methyltransferases and demethylases. Chembiochem 12(2), 254-263 (2011).
2. Current perspectives on histone demethylases. Acta Biochim. Biophys. Sin. (Shanghai) 39(2), 81-88 (2007).
3. Synthesis and activity of N-
4. Design, synthesis, enzyme-
5. Inhibitor scaffolds for 2-
6. Selective inhibitors of the JMJD2 histone demethylases: Combined nondenaturing mass spectrometric screening and crystallographic approaches. J. Med. Chem. 53(4), 1810-1818 (2010).
Symmetrically substituted dichlorophenes inhibit N-